HIP1–ALK, A Novel ALK Fusion Variant that Responds to Crizotinib

Autor: Fang, Douglas D., Zhang, Bin, Gu, Qingyang, Lira, Maruja, Xu, Qiang, Sun, Hongye, Qian, Maoxiang, Sheng, Weiqi, Ozeck, Mark, Wang, Zhenxiong, Zhang, Cathy, Chen, Xinsheng, Chen, Kevin X., Li, Jian, Chen, Shu-Hui, Christensen, James, Mao, Mao, Chan, Chi-Chung
Zdroj: In Journal of Thoracic Oncology March 2014 9(3):285-294
Databáze: ScienceDirect